Home » Authors » Karl Thiel

Articles by Karl Thiel

FDA Oversteps its Bounds for Jazz Fibromyalgia Drug

Aug. 30, 2010

Eli Lilly CEO Provides Hints About Firm's Global Direction

Aug. 3, 2010

Human Genome Project Has Yet to Revolutionize Medicine

July 6, 2010

By Creating Impassable Pathway, Biosimilar Law Could be DOA

June 1, 2010

Scariest Thing About Myriad Case? Frightening Investors

May 10, 2010

Blocked Exits and Risk Aversion Mean Tough Times for Start-ups

March 8, 2010

Health Care Reform is Dead; Long Live Health Care Reform!

Feb. 1, 2010

The Year Ahead Offers Hope and a Whole Lot of Change

Jan. 4, 2010

Looking for Pharma Growth? Go East, Young Man, Go Eas

Dec. 9, 2009

Looking for Pharma Growth? Go East, Young Man, Go East

Dec. 7, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...